Towards this end, commonly identified alterations in gene expression and pathway regulation in human STS, including altered TP53 signaling, activation of Wnt signaling, and epigenetic reprogramming were investigated in Oncopig STS cell lines (fibroblast) and tumors (leiomyosarcoma). Here, TP53 is linked to leiomyosarcoma.